Matchar, David B <br/><br/>
Testing for cytochrome P450 polymorphisms in adults with non-psychotic depression treated with selective serotonin reuptake inhibitors (SSRIs).  [electronic resource] 

 -  Evidence report/technology assessment  Jan 2007 
 - 1-77 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1530-4396 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aryl Hydrocarbon Hydroxylases--genetics<br/>Cytochrome P-450 CYP2C19<br/>Cytochrome P-450 CYP2C9<br/>Cytochrome P-450 CYP2D6--genetics<br/>Cytochrome P-450 Enzyme System--genetics<br/>Depressive Disorder--drug therapy<br/>Depressive Disorder, Major--drug therapy<br/>Genetic Testing<br/>Genotype<br/>Humans<br/>Mixed Function Oxygenases--genetics<br/>Polymorphism, Genetic--genetics<br/>Selective Serotonin Reuptake Inhibitors--adverse effects<br/>Treatment Outcome